BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32265343)

  • 21. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
    Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W
    Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.
    Wang LM; Zhang Y; Li X; Zhang ML; Zhu L; Zhang GX; Xu YM
    Brain Behav Immun; 2018 Feb; 68():44-55. PubMed ID: 28962999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aurintricarboxylic acid ameliorates experimental autoimmune encephalomyelitis by blocking chemokine-mediated pathogenic cell migration and infiltration.
    Zhang F; Wei W; Chai H; Xie X
    J Immunol; 2013 Feb; 190(3):1017-25. PubMed ID: 23267022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amelioration of experimental autoimmune encephalomyelitis by β-elemene treatment is associated with Th17 and Treg cell balance.
    Zhang R; Tian A; Zhang H; Zhou Z; Yu H; Chen L
    J Mol Neurosci; 2011 May; 44(1):31-40. PubMed ID: 21246417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis.
    Zhang J; Cheng Y; Cui W; Li M; Li B; Guo L
    J Neuroimmunol; 2014 Jan; 266(1-2):56-63. PubMed ID: 24332164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
    Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
    Front Immunol; 2019; 10():2436. PubMed ID: 31681316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.
    Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X
    Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
    Zhou Y; Leng X; Luo S; Su Z; Luo X; Guo H; Mo C; Zou Q; Liu Y; Wang Y
    J Immunol Res; 2016; 2016():5021537. PubMed ID: 28070525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
    McLaughlin PJ; McHugh DP; Magister MJ; Zagon IS
    BMC Immunol; 2015 Apr; 16():24. PubMed ID: 25906771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
    Kong W; Li H; Tuma RF; Ganea D
    Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Aqueous Extract of Tarragon on Clinical Symptoms and T Cell Differentiation in Experimental Autoimmune Encephalomyelitis.
    Nowras T; Fereidouni M; Safari H; Naseri M
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):523-532. PubMed ID: 32245296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell.
    Li X; Li TT; Zhang XH; Hou LF; Yang XQ; Zhu FH; Tang W; Zuo JP
    PLoS One; 2013; 8(8):e74108. PubMed ID: 24009768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis.
    Zheng Q; Yang T; Fang L; Liu L; Liu H; Zhao H; Zhao Y; Guo H; Fan Y; Wang L
    BMC Complement Altern Med; 2015 Mar; 15():60. PubMed ID: 25887665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.
    Serada S; Fujimoto M; Mihara M; Koike N; Ohsugi Y; Nomura S; Yoshida H; Nishikawa T; Terabe F; Ohkawara T; Takahashi T; Ripley B; Kimura A; Kishimoto T; Naka T
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9041-6. PubMed ID: 18577591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SH479, a Betulinic Acid Derivative, Ameliorates Experimental Autoimmune Encephalomyelitis by Regulating the T Helper 17/Regulatory T Cell Balance.
    Li J; Jing J; Bai Y; Li Z; Xing R; Tan B; Ma X; Qiu WW; Du C; Du B; Yang F; Tang J; Siwko S; Liu M; Chen H; Luo J
    Mol Pharmacol; 2017 May; 91(5):464-474. PubMed ID: 28213589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation.
    Cravens PD; Hussain RZ; Miller-Little WA; Ben LH; Segal BM; Herndon E; Stüve O
    PLoS One; 2016; 11(10):e0165248. PubMed ID: 27780253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.